Breadcrumb Navigation

FDG PET (oncology and infectiology)

18F-FDG is the PET tracer most commonly used in nuclear medicine today. 18F-FDG is a structurally poorly altered, radioactively labeled sugar. After injection into the body, the tracer is distributed in the tissues and is absorbed by the cells that have a high turnover of sugar (brain, heart, malignant tumors and metastases).

On the axial fused images, focal FDG additional enrichments can be assigned to the anatomical structures. Thanks to the additional CT examination, the size and local extent of the primary tumor can be determined (yellow arrow). In addition, metastases can be detected in lymph nodes or other organs, as in this case a rib metastasis (red arrow).
On the axial fused images, focal FDG additional enrichments can be assigned to the anatomical structures. Thanks to the additional CT examination, the size and local extent of the primary tumor can be determined (yellow arrow). In addition, metastases can be detected in lymph nodes or other organs, as in this case a rib metastasis (red arrow).

Patient information

Indications in oncology and infectiology

The following indications for an 18F-FDG-PET examination are established and reimbursed by the health insurance company:

  • Oncology
  • Infectiology
    • Fever of unknown origin
    • Echinococcosis
    • Large vessel vasculitis suspected
    • Suspected infection of vascular grafts
Details see PDF, page 105ff

Responsible doctors

Martin Hüllner, PD Dr. med.

Senior Attending Physician, Department of Nuclear Medicine
Deputy Clinic Director, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine
Diagnostic Neuroradiologist, Department of Nuclear Medicine

Specialties: Oncological, neurological and musculoskeletal imaging
Tel. +41 44 255 25 80

Lars Husmann, Prof. Dr. med.

Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine

Specialties: PET/CT Imaging
Tel. +41 43 253 87 99

David Kenkel, Dr. med.

Attending Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine

Specialties: Oncological imaging (PET, SPECT, CT, MRI)

Cäcilia Mader, Dr. med.

Senior Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine
Neuroradiologist, Department of Nuclear Medicine

Specialties: Oncological, neurological and musculoskeletal hybrid imaging
Tel. +41 43 253 88 02

Alexander Maurer, Dr. med.

Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine

Specialties: Oncologic imaging, Hybrid imaging of prostate cancer
Tel. +41 43 253 88 09

Michael Messerli, PD Dr. med.

Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine

Specialties: Hybrid imaging of oncological diseases (PET, SPECT, CT, MRI)
Tel. +41 43 253 88 03

For patients

As a patient, you cannot register directly for a consultation. Please have your family doctor, specialist refer you. If you have any questions, please use our contact form.

Tel. +41 44 255 35 55

For referring physicians

Simply assign your patient via registration form.

Tel. +41 44 255 35 55

Medical information hotline: 08.00-18.00 o’clock: +41 44 255 15 02